Alpine Immune Sciences
Andrew Sandler currently serves as Chief Medical Officer at Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company focused on innovative immunotherapies. Previously, Andrew held the position of Chief Medical Officer at Kiadis Pharma and served as Senior Vice President of Medical Affairs at Medivation. Andrew's extensive career includes a significant tenure at Dendreon Pharmaceuticals, where several promotions culminated in the role of CMO and Executive Vice President of Research & Development, overseeing the commercialization of Provenge®. Prior roles as CMO at Spectrum Pharmaceuticals and leadership positions at Bayer HealthCare and Seattle Genetics further highlight Andrew's expertise in medical affairs and clinical development. Andrew's academic foundation includes a Doctor of Medicine from Icahn School of Medicine at Mount Sinai and specialized training in Hematology/Oncology at UCSF.
This person is not in any offices
Alpine Immune Sciences
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- orbest-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development.